Bempikibart: A New Antibody Treatment for Alopecia Areata, and How It Differs From JAK Inhibitors
JAK inhibitors like baricitinib and ritlecitinib have gotten most of the attention in alopecia areata treatment over the past few years, and for good reason — they’re the first FDA-approved options for an autoimmune condition that used to have none. But a different drug, working through an entirely different immune pathway, just reported real trial […]